|
FDA Approves Talon’s Marqibo for Rare Leukemia Type
The FDA has approved Talon Therapeutics’ Marqibo to treat certain adult patients with a rare type of leukemia, Philadelphia chromosome negative acute lymphoblastic leukemia (ALL).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives